{"title":"6分钟步行试验中不同程度运动性去饱和COPD患者的特点及生活质量","authors":"Beiyao Gao, Siyuan Wang, Li Zhao, Hongbin Liao, Shiwei Qumu, Peijian Wang, Ting Yang, Shan Jiang","doi":"10.2147/COPD.S513089","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify predictive factors for different exercise-induced desaturation (EID) severities and evaluate health-related quality of life six months later in chronic obstructive pulmonary disease (COPD) patients.</p><p><strong>Methods: </strong>This retrospective study consecutively analyzed 116 COPD outpatients (male: 82.8% [96/116]; age: 63.48 ± 7.48 years; disease severity distribution: GOLD 1/2/3/4 = 55.8%/34.6%/7.7%/1.9%). Patients were categorized into three groups based on oxygen desaturation (SpO<sub>2</sub>) during the six-minute walk test (6MWT): non-EID (n = 52), mild-EID (n = 42), and severe-EID (n = 22). EID was classified as follows: Mild EID: SpO<sub>2</sub> decrease ≥4% with nadir SpO<sub>2</sub> ≥90%. Severe EID: SpO<sub>2</sub> decrease ≥4% with nadir SpO<sub>2</sub> ≤90%. Non EID: SpO<sub>2</sub> decrease <4% with nadir SpO<sub>2</sub> ≥90%. A six-month follow-up was conducted via telephone to record adverse events and assess quality of life using the Chinese version of the EQ-5D questionnaire, which includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, along with the EQ-VAS scale.</p><p><strong>Results: </strong>Significant differences were observed across the three groups in peripheral blood oxygen saturation (SpO<sub>2</sub>, %), peak expiratory flow (PEF, L/s), PEF (%), forced expiratory volume in the first second (FEV1, L), FEV1 (%), 6MWT distance (6MWD, m), Borg dyspnea, and Borg fatigue scores. The optimal cutoff values for predicting EID severity was 54.45% for FEV1% (AUC=0.716), 450.5 m for 6MWD (AUC = 0.761), and 94.5% for resting SpO<sub>2</sub> (AUC = 0.737). Multivariate logistic regression analysis identified low FEV1%, reduced 6MWD, and low resting SpO<sub>2</sub> as risk factors for severe EID (FEV1%: p = 0.002; 6MWD: p = 0.008; SpO<sub>2</sub>: p = 0.018. Severe EID patients had significantly lower EQ-5D index and EQ-VAS scores (EQ-5D index: p = 0.002; EQ-VAS: P = 0.005), particularly in mobility and usual activities dimensions (mobility: p = 0.001; usual activities: p = 0.038).</p><p><strong>Conclusion: </strong>Low FEV1%, reduced 6MWD, and low resting SpO<sub>2</sub> are key risk factors for severe EID, provide practical thresholds for clinical management of EID in COPD patients.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"2381-2391"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273722/pdf/","citationCount":"0","resultStr":"{\"title\":\"Characteristics and Quality of Life of Patients with COPD with Different Degrees of Exercise-Induced Desaturation on Six-minute Walk Test.\",\"authors\":\"Beiyao Gao, Siyuan Wang, Li Zhao, Hongbin Liao, Shiwei Qumu, Peijian Wang, Ting Yang, Shan Jiang\",\"doi\":\"10.2147/COPD.S513089\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To identify predictive factors for different exercise-induced desaturation (EID) severities and evaluate health-related quality of life six months later in chronic obstructive pulmonary disease (COPD) patients.</p><p><strong>Methods: </strong>This retrospective study consecutively analyzed 116 COPD outpatients (male: 82.8% [96/116]; age: 63.48 ± 7.48 years; disease severity distribution: GOLD 1/2/3/4 = 55.8%/34.6%/7.7%/1.9%). Patients were categorized into three groups based on oxygen desaturation (SpO<sub>2</sub>) during the six-minute walk test (6MWT): non-EID (n = 52), mild-EID (n = 42), and severe-EID (n = 22). EID was classified as follows: Mild EID: SpO<sub>2</sub> decrease ≥4% with nadir SpO<sub>2</sub> ≥90%. Severe EID: SpO<sub>2</sub> decrease ≥4% with nadir SpO<sub>2</sub> ≤90%. Non EID: SpO<sub>2</sub> decrease <4% with nadir SpO<sub>2</sub> ≥90%. A six-month follow-up was conducted via telephone to record adverse events and assess quality of life using the Chinese version of the EQ-5D questionnaire, which includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, along with the EQ-VAS scale.</p><p><strong>Results: </strong>Significant differences were observed across the three groups in peripheral blood oxygen saturation (SpO<sub>2</sub>, %), peak expiratory flow (PEF, L/s), PEF (%), forced expiratory volume in the first second (FEV1, L), FEV1 (%), 6MWT distance (6MWD, m), Borg dyspnea, and Borg fatigue scores. The optimal cutoff values for predicting EID severity was 54.45% for FEV1% (AUC=0.716), 450.5 m for 6MWD (AUC = 0.761), and 94.5% for resting SpO<sub>2</sub> (AUC = 0.737). Multivariate logistic regression analysis identified low FEV1%, reduced 6MWD, and low resting SpO<sub>2</sub> as risk factors for severe EID (FEV1%: p = 0.002; 6MWD: p = 0.008; SpO<sub>2</sub>: p = 0.018. Severe EID patients had significantly lower EQ-5D index and EQ-VAS scores (EQ-5D index: p = 0.002; EQ-VAS: P = 0.005), particularly in mobility and usual activities dimensions (mobility: p = 0.001; usual activities: p = 0.038).</p><p><strong>Conclusion: </strong>Low FEV1%, reduced 6MWD, and low resting SpO<sub>2</sub> are key risk factors for severe EID, provide practical thresholds for clinical management of EID in COPD patients.</p>\",\"PeriodicalId\":48818,\"journal\":{\"name\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"20 \",\"pages\":\"2381-2391\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273722/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/COPD.S513089\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S513089","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨慢性阻塞性肺疾病(COPD)患者不同运动诱导的去饱和(EID)严重程度的预测因素,并评价6个月后与健康相关的生活质量。方法:回顾性分析116例COPD门诊患者,其中男性占82.8% [96/116];年龄:63.48±7.48岁;疾病严重程度分布:GOLD 1/2/3/4 = 55.8%/34.6%/7.7%/1.9%)。根据6分钟步行试验(6MWT)期间的氧饱和度(SpO2)将患者分为三组:非eid (n = 52),轻度eid (n = 42)和严重eid (n = 22)。轻度EID: SpO2下降≥4%,最低点SpO2≥90%。重度EID: SpO2下降≥4%,最低点SpO2≤90%。非EID: SpO2降低2≥90%。通过电话进行为期六个月的随访,记录不良事件并使用中文版EQ-5D问卷评估生活质量,该问卷包括五个维度:行动能力、自我保健、日常活动、疼痛/不适和焦虑/抑郁,以及EQ-VAS量表。结果:三组患者外周血氧饱和度(SpO2, %)、呼气峰流量(PEF, L/s)、PEF(%)、第一秒用力呼气量(FEV1, L)、FEV1(%)、6MWT距离(6MWD, m)、Borg呼吸困难、Borg疲劳评分均有显著差异。预测EID严重程度的最佳截止值为:FEV1%为54.45% (AUC=0.716), 6MWD为450.5 m (AUC= 0.761),静息SpO2为94.5% (AUC= 0.737)。多因素logistic回归分析发现,低FEV1%、低6MWD和低静息SpO2是严重EID的危险因素(FEV1%: p = 0.002;6MWD: p = 0.008;SpO2: p = 0.018。严重EID患者的EQ-5D指数和EQ-VAS评分均显著降低(EQ-5D指数:p = 0.002;EQ-VAS: P = 0.005),特别是在流动性和日常活动方面(流动性:P = 0.001;日常活动:p = 0.038)。结论:低FEV1%、低6MWD、低静息SpO2是严重EID的关键危险因素,为COPD患者EID的临床管理提供了实用的阈值。
Characteristics and Quality of Life of Patients with COPD with Different Degrees of Exercise-Induced Desaturation on Six-minute Walk Test.
Objective: To identify predictive factors for different exercise-induced desaturation (EID) severities and evaluate health-related quality of life six months later in chronic obstructive pulmonary disease (COPD) patients.
Methods: This retrospective study consecutively analyzed 116 COPD outpatients (male: 82.8% [96/116]; age: 63.48 ± 7.48 years; disease severity distribution: GOLD 1/2/3/4 = 55.8%/34.6%/7.7%/1.9%). Patients were categorized into three groups based on oxygen desaturation (SpO2) during the six-minute walk test (6MWT): non-EID (n = 52), mild-EID (n = 42), and severe-EID (n = 22). EID was classified as follows: Mild EID: SpO2 decrease ≥4% with nadir SpO2 ≥90%. Severe EID: SpO2 decrease ≥4% with nadir SpO2 ≤90%. Non EID: SpO2 decrease <4% with nadir SpO2 ≥90%. A six-month follow-up was conducted via telephone to record adverse events and assess quality of life using the Chinese version of the EQ-5D questionnaire, which includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, along with the EQ-VAS scale.
Results: Significant differences were observed across the three groups in peripheral blood oxygen saturation (SpO2, %), peak expiratory flow (PEF, L/s), PEF (%), forced expiratory volume in the first second (FEV1, L), FEV1 (%), 6MWT distance (6MWD, m), Borg dyspnea, and Borg fatigue scores. The optimal cutoff values for predicting EID severity was 54.45% for FEV1% (AUC=0.716), 450.5 m for 6MWD (AUC = 0.761), and 94.5% for resting SpO2 (AUC = 0.737). Multivariate logistic regression analysis identified low FEV1%, reduced 6MWD, and low resting SpO2 as risk factors for severe EID (FEV1%: p = 0.002; 6MWD: p = 0.008; SpO2: p = 0.018. Severe EID patients had significantly lower EQ-5D index and EQ-VAS scores (EQ-5D index: p = 0.002; EQ-VAS: P = 0.005), particularly in mobility and usual activities dimensions (mobility: p = 0.001; usual activities: p = 0.038).
Conclusion: Low FEV1%, reduced 6MWD, and low resting SpO2 are key risk factors for severe EID, provide practical thresholds for clinical management of EID in COPD patients.
期刊介绍:
An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals